title: Ipilimumab.
authors.forename: Vernon K
authors.initials: VK
authors.lastname: Sondak
authors.forename: Keiran S M
authors.initials: KS
authors.lastname: Smalley
authors.forename: Ragini
authors.initials: R
authors.lastname: Kudchadkar
authors.forename: Seden
authors.initials: S
authors.lastname: Grippon
authors.forename: Peter
authors.initials: P
authors.lastname: Kirkpatrick
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D060908:CTLA-4 Antigen; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D000074324:Ipilimumab